CYT-216; recombinant human IGF-1

Ended Purchase Order Awarded Last action

Contract number
W81XWH15P0296
Awardee
Awarding agency
Obligated
$99,990

Award facts

Opportunity
Contract value 100% obligated
$99,990.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325414 Biological Product (except Diagnostic) Manufacturing
PSC
6640 Laboratory Equipment And Supplies
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 3 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Montgomery Village, MD 20879, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

This federal contract award, W81XWH15P0296, was issued by the U.S. Army Medical Command (MEDCOM) to Eenzyme LLC, a small business contractor. The $99,990.00 firm-fixed-price purchase order is for the delivery of CYT-216, recombinant human insulin-like growth factor 1 (IGF-1). This contract was set aside for small businesses. Eenzyme LLC, an Asian-Pacific American-owned limited liability company, has been awarded this contract to provide the specified product to the government.

Quick answers

Who was awarded contract W81XWH15P0296?

W81XWH15P0296 was awarded to Eenzyme, LLC by Medical Command (Department of the Army) on July 14, 2015.

How much is contract W81XWH15P0296 worth?

The government has obligated $99,990 on W81XWH15P0296.

Was contract W81XWH15P0296 competed?

The extent of competition for W81XWH15P0296 was full and open competition after exclusion of sources. The government received 3 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login